Exclusive TCRVß chain usage of ex vivo generated minor Histocompatibility antigen HA-1-specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRVß spectratyping.
Author(s):
Verdijk, R.M.; Mutis, T.; Wilke, M.; Pool, J.; Schrama, E.; Brand, A.; Goulmy, E.A.J.M.